Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Lançon

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
Presse Medicale (Paris, France : 1983)|May 15, 2013
[Tabacco during pregnancy: a risk factor for addiction and psychiatric diseases?]Christophe Lançon
BMC Psychiatry|July 27, 2006
Duloxetine compared with fluoxetine and venlafaxine: use of meta-regression analysis for indirect comparisonsLaurent Eckert, Christophe Lançon
Presse Medicale (Paris, France : 1983)|February 24, 2006
[Neurofibromatosis type 1: psychiatric disorders and quality of life impairment]Raoul Belzeaux, Christophe Lançon
La Revue Du Praticien|May 6, 2015
[Acute delirium in decompensated schizophrenia and bipolar disorder]Catherine Faget-Agius, Christophe Lançon
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 11, 2006
Pharmacoeconomic modelling in schizophrenia. Trap or support for decision makers?Karina Hansen, Christophe Lançon, Mondher Toumi
Current Medical Research and Opinion|May 13, 2003
The ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in FranceMireille Bonierbale, Christophe Lançon, Jean Tignol
Presse Medicale (Paris, France : 1983)|May 25, 2013
[Virtual reality in the treatment of mental disorders]Eric Malbos, Laurent Boyer, Christophe Lançon
Revue De L'Infirmiere|August 26, 2020
[Climate impact on mental health]Guillaume Fond, Christophe Lançon, Pascal Auquier, et al.
Presse Medicale (Paris, France : 1983)|July 4, 2012
[Psychostimulants in the treatment of depression]Raphaëlle Richieri, Marc Adida, Laurent Boyer, et al.
L'Encephale|February 8, 2025
Treatment resistant depression: A case of Muenke syndromeMélanie Faugere, Michel Cermolacce, Raphaëlle Richieri, et al.
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
Presse Medicale (Paris, France : 1983)|May 15, 2013
[Tabacco during pregnancy: a risk factor for addiction and psychiatric diseases?]Christophe Lançon
BMC Psychiatry|July 27, 2006
Duloxetine compared with fluoxetine and venlafaxine: use of meta-regression analysis for indirect comparisonsLaurent Eckert, Christophe Lançon
Presse Medicale (Paris, France : 1983)|February 24, 2006
[Neurofibromatosis type 1: psychiatric disorders and quality of life impairment]Raoul Belzeaux, Christophe Lançon
La Revue Du Praticien|May 6, 2015
[Acute delirium in decompensated schizophrenia and bipolar disorder]Catherine Faget-Agius, Christophe Lançon
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 11, 2006
Pharmacoeconomic modelling in schizophrenia. Trap or support for decision makers?Karina Hansen, Christophe Lançon, Mondher Toumi
Current Medical Research and Opinion|May 13, 2003
The ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in FranceMireille Bonierbale, Christophe Lançon, Jean Tignol
Presse Medicale (Paris, France : 1983)|May 25, 2013
[Virtual reality in the treatment of mental disorders]Eric Malbos, Laurent Boyer, Christophe Lançon
Revue De L'Infirmiere|August 26, 2020
[Climate impact on mental health]Guillaume Fond, Christophe Lançon, Pascal Auquier, et al.
Presse Medicale (Paris, France : 1983)|July 4, 2012
[Psychostimulants in the treatment of depression]Raphaëlle Richieri, Marc Adida, Laurent Boyer, et al.
L'Encephale|February 8, 2025
Treatment resistant depression: A case of Muenke syndromeMélanie Faugere, Michel Cermolacce, Raphaëlle Richieri, et al.
Pageof 13